MD
Publicaties op Oncologisch.com
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and ...
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High...
Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patiënten met newly diagnosed myeloma ine...
Carfilzomib-CyD of KRd plus ASCT bij myeloom: FORTE fase II
Aangepaste Rd versus continue Rd bij ouderen met myeloom: fase III